The high prevalence of TERT promoter mutations was confirmed in most tumour types such as glioma, bladder cancer, oral cavity carcinoma as well as melanoma and non-melanoma skin cancers (Zehir et al., 2017). This evidence concerns the gene TERT and melanoma.